November 30, 2020

A shot in the arm

Share on facebook
Share on twitter
Share on linkedin
Share on email

In Short

The outstanding risk rally in November may appear reckless amid resurgent Covid cases, persistent risks of a hard Brexit and a (likely) split new US government taking office in January. The broad-based rally (comprising also Credit, EMs and Commodities) may seem reckless. Lockdowns in Europe may persist over the winter, while laissez-faire in the US warrants a sharply rising death toll. Daily Covid casualties exceeded 2,000 in the US even before Thanksgiving, a potential national superspreader event.
A shot in the arm
Share on facebook
Share on twitter
Share on linkedin
Share on email

Highlights:

  • The outstanding risk rally in November may appear reckless amid resurgent Covid cases, persistent risks of a hard Brexit and a (likely) split new US government taking office in January.
  • Yet markets are right in pricing recent vaccine news as a game changer for the pandemic while central banks remain committed to extended stimulus.
  • We thus slightly extend our pro-risk tilt, with a sizeable overweight in Credit and (more prudently) in Equities. A weakening US dollar favours exposure to EMs. Cash and Core Government Bonds remain unattractive.

Download the full publication below

 
MARKET PERSPECTIVES 12/2020 - A SHOT IN THE ARM
December 18th, 2020

Also interesting

Financial-and-technical-data-analysis-chart
July 30, 2021
Market Commentary

Market Commentary: Q2 reporting season is doing well but annual growth has peaked

size 3
July 29, 2021
Market Commentary

COVID-19 UPDATE Facts & Figures – 29/07/2021

federal-reserve-building-with-twenty-dollar-bill-on-grunge-texture-picture-id175716236
July 28, 2021
Market Commentary

MARKET COMMENTARY – The Fed: the recovery is on track, tapering is approaching